Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells
Authors:
- 12 February 2010
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 17 (7) , 447-456
Abstract
Gene therapy is being examined as a potential strategy for treating prostate cancer. Serotype 5 adenovirus (Ad.5) is routinely used as a vector for transgene delivery. However, the infectivity of Ad.5 is dependent on Coxsackie-adenovirus receptors (CARs); many tumor types show a reduction in this receptor in vivo, thereby limiting therapeutic gene transduction. Serotype chimerism is one approach to circumvent CAR deficiency; this strategy is used to generate an Ad.5/3-recombinant Ad that infects cancer cells through Ad.3 receptors in a CAR-independent manner. In this report, the enhanced transgene delivery and efficacy of Ad.5/3-recombinant virus was evaluated using an effective wide-spectrum anticancer therapeutic melanoma differentiation-associated gene-7/interleukin-24 (mda-7/IL-24). Our data show that in low CAR human prostate cancer cells (PC-3), a recombinant Ad.5/3 virus delivering mda-7/IL-24 (Ad.5/3-mda-7) is more efficacious than an Ad.5 virus encoding mda-7/IL-24 (Ad.5-mda-7) in infecting tumor cells, expressing MDA-7/IL-24 protein, inducing cancer-specific apoptosis, inhibiting in vivo tumor growth and exerting an antitumor ‘bystander’ effect in a nude mouse xenograft model. Considering the fact that Ad.5-mda-7 has shown significant objective responses in a phase I clinical trial for solid tumors, Ad.5/3-mda-7 is predicted to exert enhanced therapeutic benefit in patients with prostate cancer.Keywords
This publication has 42 references indexed in Scilit:
- Prostate cancerThe Lancet, 2008
- Characterization of infectivity of knob-modified adenoviral vectors in gliomaCancer Biology & Therapy, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cellsJournal of Neurosurgery, 2007
- A Mosaic Fiber Adenovirus Serotype 5 Vector Containing Reovirus σ1 and Adenovirus Serotype 3 Knob Fibers Increases Transduction in an Ovarian Cancer Ex vivo System via a Coxsackie and Adenovirus Receptor–Independent PathwayClinical Cancer Research, 2007
- Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activityApoptosis, 2006
- Advanced Generation Adenoviral Virotherapy Agents Embody Enhanced Potency Based upon CAR-Independent TropismClinical Cancer Research, 2006
- Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitorsCancer Gene Therapy, 2006
- Molecular markers and determinants of prostate cancer metastasisJournal of Cellular Physiology, 2001
- Early Androgen Deprivation for Prostate Cancer?New England Journal of Medicine, 1999